Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Jeffrey A. Bluestone
Papers
Science Translational Medicine
November 2015
Authors and Affiliates
Jeffrey A. Bluestone1, Jane H. Buckner2, Mark Fitch3, Stephen E. Gitelman4, Shipra Gupta2, Marc K. Hellerstein3, Kevan C. Herold5, Angela Lares1, Michael R. Lee1, Kelvin Li6, Weihong Liu1, S. Alice Long2, Lisa M. Masiello1, Vinh Nguyen7, Amy L. Putnam1, Mary Rieck1, Peter H. Sayre8 and Qizhi Tang7 1 Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA. 2 Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA. 3 Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA. 4 Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94143, USA. 5 Departments of Immunobiology and Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. 6 KineMed Inc., Emeryville, CA 94608, USA. 7 Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA. 8 Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.